|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Verdezyne, Inc.
| | | Phone: | (760) 707-5200 | Year Established: | 2005 | Main Contact: | E. William Radany, Ph.D., President & CEO | | Other Contacts: | Joseph V. Galluzzo, P.E., VP, Global Projects Jenna Ngian, VP, Global Sales and Supply Chain Bill Evanko, P.E., VP, Engineering José M. Laplaza, Ph.D., VP, Development Tom Beardslee, Ph.D., VP, R&D Nancy Oleski, Ph.D., J.D., Senior VP, Intellectual Property & General Counsel Stephen Picataggio, Ph.D., CSO
| | Company Description | Verdezyne (formerly CODA Genomics) is a synthetic biology company offering biobased chemicals developed using proprietary metabolic pathway engineering tools. The company’s first product, BIOLON® DDDA, earned the USDA Certified Biobased Product label, and is available worldwide. Current investors in Verdezyne include BP Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby. | |
|
|
|
|
|